IRhythm Technologies Operating Income 2015-2024 | IRTC

IRhythm Technologies operating income from 2015 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
IRhythm Technologies Annual Operating Income
(Millions of US $)
2023 $-125
2022 $-114
2021 $-100
2020 $-44
2019 $-55
2018 $-46
2017 $-28
2016 $-16
2015 $-22
2014 $-15
IRhythm Technologies Quarterly Operating Income
(Millions of US $)
2024-09-30 $-50
2024-06-30 $-23
2024-03-31 $-38
2023-12-31 $-39
2023-09-30 $-28
2023-06-30 $-19
2023-03-31 $-40
2022-12-31 $-21
2022-09-30 $-21
2022-06-30 $-23
2022-03-31 $-49
2021-12-31 $-32
2021-09-30 $-23
2021-06-30 $-17
2021-03-31 $-27
2020-12-31 $-10
2020-09-30 $-5
2020-06-30 $-20
2020-03-31 $-9
2019-12-31 $-18
2019-09-30 $-18
2019-06-30 $-11
2019-03-31 $-8
2018-12-31 $-14
2018-09-30 $-9
2018-06-30 $-12
2018-03-31 $-11
2017-12-31 $-11
2017-09-30 $-6
2017-06-30 $-6
2017-03-31 $-5
2016-12-31 $-4
2016-09-30 $-3
2016-06-30 $-4
2016-03-31 $-5
2015-12-31
2015-09-30 $-6
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.316B $0.493B
iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $9.226B 0.00
Inspire Medical Systems (INSP) United States $5.656B 176.38
Hims & Hers Health (HIMS) United States $5.534B 140.72
Enovis (ENOV) United States $2.608B 17.68
Privia Health (PRVA) United States $2.587B 215.60
Azenta (AZTA) United States $2.209B 110.15
Omnicell (OMCL) United States $2.116B 69.23
10x Genomics (TXG) United States $1.732B 0.00
Clover Health Investments (CLOV) United States $1.689B 0.00
Schrodinger (SDGR) United States $1.518B 0.00
Phreesia (PHR) United States $1.148B 0.00
Butterfly Network (BFLY) United States $0.690B 0.00
Standard BioTools (LAB) United States $0.596B 0.00
Talkspace (TALK) United States $0.583B 0.00
Fulgent Genetics (FLGT) United States $0.547B 0.00
Definitive Healthcare (DH) United States $0.505B 87.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.268B 0.00
TruBridge (TBRG) United States $0.247B 71.91
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
American Well (AMWL) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.112B 0.00
P3 Health Partners (PIII) United States $0.076B 0.00
HeartBeam (BEAT) United States $0.074B 0.00
111 (YI) China $0.052B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.044B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zepp Health (ZEPP) China $0.037B 0.00
Movano (MOVE) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
MSP Recovery (LIFW) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00